Skip to main content

MoneyWorks4Me

Dr Reddys Laboratories board to approve audited financial results

19 Apr 2016 Evaluate

Dr Reddys Laboratories has informed that a meeting of the Board of Directors of the Company will be held on May 12, 2016, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2016 and recommend dividend, if any, for the financial year 2015-16.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..